The oncoplot and lollipop plot showed higher mutation frequencies of KRAS, NRAS, and TP53 in the high-risk group, particularly for TP53, indicating its key role in MM progression (Figures 6C–H). This evidence concerns the gene KRAS and Miyoshi myopathy.